![Jim Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jim Murray worked as the Head of Clinical Operations at Rhythm Pharmaceuticals, Inc. from 2017 to 2019, and at Merrimack Pharmaceuticals, Inc. from 2003 to 2017.
He also worked as the Vice President of Clinical at TScan Therapeutics, Inc. Additionally, he worked as the Head of Clinical Operations at Repertoire Immune Medicines, Inc. from 2019 to 2021.
Mr. Murray received his undergraduate degree from Boston College.
Anciens postes connus de Jim Murray
| Sociétés | Poste | Fin |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 06/02/2024 |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Corporate Officer/Principal | 01/03/2021 |
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2019 |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | 01/03/2017 |
Formation de Jim Murray
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
